Guided Therapeutics is set to exhibit its LuViva Advanced Cervical Scan product in Dusseldorf, Germany.
LuViva Cervical Scan is designed as a painless test that has the potential to improve the early detection of cervical precancers.
LuViva utilizes proprietary technology to detect cancers and precancers quickly by analyzing light reflected from the cervix.
The technology distinguishes normal and diseased tissue by detecting biochemical and morphological changes at the cellular level.
Guided Therapeutics international distribution manager Melissa White said based on their clinical results and market studies, they believe that LuViva will appeal to distributors looking to meet the demand of providing products that improve efficiency and the level of patient care.